Statera BioPharma (STU:7CB) Pretax Margin %: % (As of Sep. 2022)


What is Statera BioPharma Pretax Margin %?

Statera BioPharma STU:7CB 20 Pretax Margin % is % as of Sep. 2022. GuruFocus rates STU:7CB with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Statera BioPharma's Pre-Tax Income for the three months ended in Sep. 2022 was €-3.39 Mil. Statera BioPharma's Revenue for the three months ended in Sep. 2022 was €0.00 Mil. Therefore, Statera BioPharma's pretax margin for the quarter that ended in Sep. 2022 was %.

The historical rank and industry rank for Statera BioPharma's Pretax Margin % or its related term are showing as below:


STU:7CB's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Statera BioPharma  (STU:7CB) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Statera BioPharma Pretax Margin % Related Terms

Statera BioPharma Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Pretax Margin % Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Pretax Margin %
0.00 0.00 0.00

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:7CB vs NRBO, PALI, BLCM: Pretax Margin % Comparison

For the Biotechnology subindustry, Statera BioPharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Pretax Margin % falls into.


Statera BioPharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Statera BioPharma's Pretax Margin for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-90.159/0
= %

Statera BioPharma's Pretax Margin for the quarter that ended in Sep. 2022 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-3.391/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Statera BioPharma (STU:7CB) has a Pretax Margin % of % as of Sep. 2022. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's Pretax Margin % too high?
Statera BioPharma's current Pretax Margin % is %. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's Pretax Margin % compare to NRBO and PALI?
Statera BioPharma's Pretax Margin % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (STU:7CB) has a current Pretax Margin % of %. The current Pretax Margin % is %. Statera BioPharma's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Statera BioPharma (STU:7CB), the current Pretax Margin % is % as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.